Arie Belldegrun

Arie Belldegrun

Founder at KRONOS BIO, INC.

Net worth: 37 M $ as of 2024-03-30

74 year
Health Technology
Finance
Commercial Services

Profile

Arie S. Belldegrun is an entrepreneur and businessperson who founded 6 companies, among them: Kite Pharma, Inc., Allogene Therapeutics, Inc. and Agensys, Inc. and who has been at the head of 16 different companies. Presently, he holds the position of Chairman & Partner at Two River Group Holdings LLC, Chairman for Two River Group Management LLC, Chairman at Bellco Capital LLC (which he founded in 2003), Chairman at Two Rivers Consulting Corp., Chairman for UroGen Pharma Ltd., Chairman & Partner at Two River Consulting LLC, Executive Chairman of Allogene Therapeutics, Inc. (which he founded in 2017), Chairman of Kronos Bio, Inc., Co-Chairman at Breakthrough Properties LLC, Senior Managing Director at VV Manager LLC (which he founded in 2017), Senior Managing Director at Vida Ventures LLC (which he founded in 2017) (a subsidiary of VV Manager LLC) and Chairman of Technology Assessment Group. Arie S. Belldegrun is also Director & Professor at UCLA Institute of Urologic Oncology, Head-Urologic Oncology Division at David Geffen School of Medicine and Senior Managing Director at Vida Ventures LLC (he founded the company in 2017) and on the board of 5 other companies. Dr. Belldegrun previously was Chairman of Arno Therapeutics, Inc. and Non-Executive Chairman at Arno Therapeutics, Inc. (a subsidiary of Arno Therapeutics, Inc.), Chairman, President & Chief Executive Officer at Equinor ASA, Director at Agensys, Inc. (he founded the company in 1997), Executive Chairman, President & CEO at Kite Pharma, Inc. (he founded the company in 2009), Chairman-Molecular Biological Technology Committee at American Urological Association Education & Research, Inc., Researcher at National Cancer Institute and Member of Los Angeles Economy & Jobs Committee. Arie S. Belldegrun received a doctorate from The Hebrew University Hadassah Medical School and a graduate degree from Weizmann Institute of Science.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-01-24 6,576,979 ( 3.89% ) 29 M $ 2024-03-30
2023-09-06 408,693 ( 1.20% ) 6 M $ 2024-03-30
2023-06-21 679,575 ( 1.13% ) 883 448 $ 2024-03-30
2023-06-15 589,662 ( 0.04% ) 684 008 $ 2024-03-30

Arie Belldegrun active positions

CompaniesPositionStart
UROGEN PHARMA LTD. Chairman 2012-09-30
ALLOGENE THERAPEUTICS, INC. Founder 2017-10-31
KRONOS BIO, INC. Founder 2017-06-01
GINKGO BIOWORKS HOLDINGS, INC. Director/Board Member -
Director/Board Member 2019-09-30
Director/Board Member -
Breakthrough Services LLC Chairman 2019-03-31
Founder 2003-12-31
Founder 2020-05-31
░░░ ░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░ ░░░░░░░ ░░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░ ░░░░ ░░░░░░░ -
░░░░░ ░░░░░░ ░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
All active positions of Arie Belldegrun

Former positions of Arie Belldegrun

CompaniesPositionEnd
░░░░ ░░░░░░ ░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Arie Belldegrun's experience

Training of Arie Belldegrun

Weizmann Institute of Science Graduate Degree
The Hebrew University Hadassah Medical School Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Arie Belldegrun's experience

Connections

100 +

1st degree connections

42

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies8
TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Health Technology

EQUINOR ASA

Energy Minerals

ARNO THERAPEUTICS, INC.

Health Technology

UROGEN PHARMA LTD.

Health Technology

ALLOGENE THERAPEUTICS, INC.

Health Technology

KRONOS BIO, INC.

Health Technology

GINKGO BIOWORKS HOLDINGS, INC.

Health Services

CAPRICOR THERAPEUTICS, INC.

Health Technology

Private companies31
Email Real Estate.com, Inc.

Finance

Finance

Finance

Health Technology

Arno Therapeutics, Inc. /Old/

Health Technology

Commercial Services

Commercial Services

Health Technology

Miscellaneous

Commercial Services

Los Angeles Economy & Jobs Committee

Health Technology

Bioscience for the State of California

Finance

Health Technology

UCLA Institute of Urologic Oncology

The American Association of Genitourinary Surgeons

Technology Services

Health Technology

Health Technology

Commercial Services

Finance

Commercial Services

Finance

Finance

Breakthrough Services LLC

Health Technology

Finance

Finance

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Arie Belldegrun